NCT07037784

Brief Summary

The purpose of this study is to use the OXYFLEX® device in real care conditions during the hospital management of a population of patients from various hospital services. These services include patients from the severe trauma pathway, intensive care, the polyvalent intensive care unit, and the operating room. The objective is to assess the reliability of the data collected by the OXYFLEX® biosensor compared to those obtained from standard monitoring used in these different services and conditions.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
May 2026Jan 2027

First Submitted

Initial submission to the registry

June 6, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 26, 2025

Completed
10 months until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

April 14, 2026

Status Verified

April 1, 2026

Enrollment Period

1 month

First QC Date

June 6, 2025

Last Update Submit

April 13, 2026

Conditions

Keywords

biosensorearly warning scorereal care conditionstraumatologyanesthesiaintensive care

Outcome Measures

Primary Outcomes (5)

  • heart rate measurement

    The data collected by the OXYFLEX biosensor will be compared to data from standard monitoring using concordance tests, such as the Bland-Altman test, the Intraclass Correlation Coefficient (ICC), and the mean of absolute errors. These analyses will allow for the evaluation of the accuracy and reproducibility of the measurements taken with the OXYFLEX biosensor.

    for a maximum of 10 hours

  • respiratory rate measurement

    The data collected by the OXYFLEX® biosensor will be compared to data from standard monitoring using concordance tests, such as the Bland-Altman test, the Intraclass Correlation Coefficient (ICC), and the mean of absolute errors. These analyses will allow for the evaluation of the accuracy and reproducibility of the measurements taken with the OXYFLEX® biosensor.

    for a maximum of 10 hours

  • temperature measurement

    The data collected by the OXYFLEX® biosensor will be compared to data from standard monitoring using concordance tests, such as the Bland-Altman test, the Intraclass Correlation Coefficient (ICC), and the mean of absolute errors. These analyses will allow for the evaluation of the accuracy and reproducibility of the measurements taken with the OXYFLEX® biosensor.

    for a maximum of 10 hours

  • pulse oxygen saturation measurement

    The data collected by the OXYFLEX® biosensor will be compared to data from standard monitoring using concordance tests, such as the Bland-Altman test, the Intraclass Correlation Coefficient (ICC), and the mean of absolute errors. These analyses will allow for the evaluation of the accuracy and reproducibility of the measurements taken with the OXYFLEX® biosensor.

    for a maximum of 10 hours

  • hemoglobin measurement

    The data collected by the OXYFLEX® biosensor will be compared to data from standard monitoring using concordance tests, such as the Bland-Altman test, the Intraclass Correlation Coefficient (ICC), and the mean of absolute errors. These analyses will allow for the evaluation of the accuracy and reproducibility of the measurements taken with the OXYFLEX® biosensor.

    for a maximum of 10 hours

Secondary Outcomes (3)

  • Conduct a clinical relevance analysis of the measurements collected by the OXYFLEX® biosensor

    for a maximum of 10 hours

  • Evaluate the data loss rate measured by the OXYFLEX®biosensor, based on the percentage of missing data for each parameter, in relation to the number of expected observations (per minute and/or per hour) over the total monitoring duration.

    for a maximum of 10 hours

  • Investigate the factors impacting the accuracy of measurements and the relevance of data collected by the OXYFLEX®biosensor

    for a maximum of 10 hours

Study Arms (1)

Patients managed in anesthesia, rehabilitation/instensive care unit and traumatology services.

EXPERIMENTAL

Demonstrate the relevance of the data collected from patients treated in different hospital departments, including critical emergencies, intensive care, general intensive care units, and the operating room.

Other: Continuous monitoring of vital constants with OXYFLEX® biosensor.

Interventions

The comparison of physiological data (heart rate, respiratory rate, temperature, pulse oxygen saturation, hemoglobin levels) collected by the OXYFLEX® biosensor with those obtained through standard monitoring over a maximum duration of 10 hours.

Patients managed in anesthesia, rehabilitation/instensive care unit and traumatology services.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient (≥ 18 years old);
  • Patient taken care of :
  • in severe traum pathway in the emergency services department
  • or in the operating room for a general anesthesia procedur or locoregional anesthesia planned for a surgical duration grater than 2 hours
  • or admitted to intesive care/ general intensive care units.

You may not qualify if:

  • Opposition from the patient or their family to participate in the research ;
  • Pregnant, parturient or breastfeeding woman ;
  • Patient under judical protection (guardianship, curatorship …) or legal safeguarding ;
  • Inability to wear the headband and the sensor (in particular : intracranial neurosurgery, othorhinolaryngology or maxillofacial surgery, debilitating trauma to the head or face …) ;
  • Any other reason that, in the investigator's opinion, could interfere with the evaluation of the study objectives.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HIA Ste Anne

Toulon, Var, 83000, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2025

First Posted

June 26, 2025

Study Start

May 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

April 14, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations